Atea Pharmaceuticals, Inc.
AVIR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001593899
No open-market purchases or sales by Atea Pharmaceuticals, Inc. insiders were filed in the last 90 days; 124 institutions reported holding it in 13F filings for Q2 2026, worth $276.4M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Atea Pharmaceuticals, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 105
- −8 vs. Q1 2024
- Shares held
- 56.7M
- +2.33M (+4.3%) vs. Q1 2024
- Total value
- $187.7M
- −$32.0M (−14.6%) vs. Q1 2024
- New holders
- 13
- 36 more added
- Sold out
- 21
- 37 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AVIR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 124 | $276.4M |
| Q1 2026 | 127 | $322.8M |
| Q4 2025 | 111 | $203.5M |
| Q3 2025 | 115 | $154.2M |
| Q2 2025 | 107 | $189.7M |
| Q1 2025 | 104 | $158.3M |
| Q4 2024 | 107 | $188.7M |
| Q3 2024 | 108 | $194.0M |
| Q2 2024 | 105 | $187.7M |
| Q1 2024 | 113 | $219.6M |
| Q4 2023 | 108 | $168.3M |
| Q3 2023 | 119 | $170.6M |
| Q2 2023 | 133 | $213.3M |
| Q1 2023 | 131 | $190.2M |
| Q4 2022 | 131 | $278.1M |
| Q3 2022 | 126 | $326.8M |
| Q2 2022 | 128 | $408.7M |
| Q1 2022 | 127 | $396.6M |
| Q4 2021 | 143 | $479.2M |
| Q3 2021 | 142 | $1.99B |
| Q2 2021 | 104 | $1.27B |
| Q1 2021 | 82 | $3.20B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Atea Pharmaceuticals, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Frazier Financial Advisors, LLC | 120 | $398 | 0.00% | 00.0% | Unchanged |
| Smartleaf Asset Management LLC | 46 | $155 | 0.00% | +46 | New |
| Colonial Trust Advisors | 46 | $152 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 20 | $0 | 0.00% | +20 | New |
| Covestor Ltd | 118 | $0 | 0.00% | +118 | New |
| Millennium Management LLC | 0 | $0 | 0.00% | −212,763−100.0% | Sold out |
| Susquehanna Portfolio Strategies, LLC | 0 | $0 | 0.00% | −80,830−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −67,111−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −37,779−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −36,200−100.0% | Sold out |
| Numerai GP LLC | 0 | $0 | 0.00% | −22,580−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −21,163−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −20,809−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −19,071−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −10,519−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −8,522−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −6,230−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −3,400−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −2,900−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −2,613−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −1,641−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −319−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −99−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −75−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −24−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |